Navigation Links
Digitas Health Expands Adding Two Key Locations
Date:7/27/2009

PHILADELPHIA, July 27 /PRNewswire/ -- Digitas Health, Medical Marketing & Media magazine's 2009 Agency of the Year, today announces the opening of two key new locations in London and Boston. This move is a strategic part of the agency's 2010 growth plan. Digitas Health has experienced increased annual revenue growth of approximately 50 percent in each of the last three years, 14 new client brand wins over the past 12 months, and has received substantial recognition in the form of awards and market eminence.

Digitas Health London

The Digitas Health London office marks the beginning of the agency's international expansion efforts, beginning in Europe. The company has appointed June Dawson as senior vice president, managing director.

"The healthcare system worldwide is being revolutionized by digital channels that change the very nature of how pharmaceutical companies and brands relate to patients and doctors alike. As budgets shift rapidly to favor these new channels, our clients are pushing our work across borders at an increasing pace. Our international expansion begins in London, a city that will serve as our European gateway office," said David Kramer, CEO, Digitas Health.

June Dawson previously served as digital business director for the London office of Ogilvy Healthworld, She brings more than a decade of pharmaceutical interactive marketing to the role. Her rich career has included work in integrated communications, public relations and journalism, and she has led marketing efforts for many of the world's leading pharmaceutical brands.

The UK is home to two of the leading 10 pharmaceutical corporations, GlaxoSmithKline and AstraZeneca, who, in 2007, comprised 10.1% of the global market share. (1) Pharmaceuticals are one of Britain's leading manufacturing sectors, bringing in a trade surplus of 4.3 billion pounds Sterling in 2007. (2)

Digitas Health Boston

Digitas Health Boston is located within the Boston headquarters of parent company Digitas, which offers a deep reservoir of talent and represents an important extension of the health brand's domestic footprint. As the nature of healthcare marketing becomes more sophisticated, Digitas Health is eager to draw on the skill sets of those who have launched some the world's most creative and successful marketing campaigns for clients across leading consumer industries such as automotive, hospitality and finance, and to share that knowledge base across the agency. Serving as the lead marketing and creative executives in Boston are Kirk Williamson, SVP/Marketing and Michael Tiedemann, SVP/Creative, both of whom bring a rich background of accomplishment.

"A simultaneous expansion to sister city Boston allows us the opportunity to reach the talented people within Digitas and beyond who have healthcare and emerging media experience and the significant interest to expand this very successful Digitas Health concept for our clients across the globe," said Kramer.

Leading marketing efforts, Kirk Williamson brings 18 years of consumer and healthcare marketing and general management experience to the role, including several years with Gillette/Procter & Gamble, Bristol-Myers Squibb, and Frito-Lay. He also served as an independent consultant in the consumer health and device markets.

As creative lead, Michael Tiedemann transitioned to the role from parent company Digitas, where he had worked for a decade as the relationship creative lead for many of the company's highest profile clients in the automotive and financial services industries. Additionally, as creative director for the Digital Solutions Group at Prodigious, a Digitas company that is the world's only standalone, global digital productions company, Tiedemann standardized the user experiences across multiple brands for a major client.

With the abundance of life science companies and robust selection of universities and leading scientific research institutions, Boston ranks number one on the list of the largest life science clusters in the U.S. (3) With more than 700 pharmaceutical, medical device and biotech companies, Massachusetts is also first in the nation in the number of life science patents per capita. (4)

Digitas Health Global

Now with offices in London, Boston, New York and Philadelphia, Digitas Health has a global presence and serves clients in the most highly concentrated areas for the pharmaceutical, bioscience, medical device and consumer health industries.

Digitas Health has enjoyed a long period of growth and accolades. The company's creative work was most recently recognized by the 2009 Webby Awards, winning the Webby for the pharmaceutical category, and with multiple Gold wins at the DTC awards.

About Digitas Health

Counting as clients many of the world's leading pharmaceutical, bioscience, and medical device companies, Digitas Health is a next-generation marketing agency that helps build healthcare brands that patients, caregivers, and healthcare professionals feel confident turning to and recommending when they are sick, in need, or helping others. With offices in Philadelphia, New York, Boston and London, Digitas Health is a unit of Digitas, leading global digital marketing and media agency and a member of the Paris-based Publicis Groupe S.A. (Euronext Paris: FR0000130577), the world's fourth largest communications group, second largest media counsel and buying group, and a global leader in digital and healthcare communications.

www.digitashealth.com | Twitter @Digitas_Health | Facebook: Digitas Health Fan Page

(1) IMS Dataview, 2007

(2) HM Revenue & Customs, 2007

(3) Milken Institute, The Greater Philadelphia Life Sciences Cluster 2009: An Economic and Comparative Assessment, May 2009

(4) Deloitte research and Massachusetts Biotechnology Council, Strategic Outlook for 2015 and Strategic Plan, May 2009

    Media Contacts:
    Carly Kuper
    215.399.3357
    ckuper@digitashealth.com

    Shireen Crowe
    + 44 7879 417 177
    shireen.crowe@direct-pr.co.uk


'/>"/>
SOURCE Digitas Health
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
3. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
6. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
7. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
8. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
9. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... Conn. (PRWEB) , ... April 28, 2016 , ... ... financing and ongoing support for Connecticut's innovative, growing companies, today announced the launch ... health and financial technology (fintech) companies. , “VentureClash looks to attract ...
(Date:4/27/2016)... ... April 27, 2016 , ... ... testing technology at the Spring 2016 Marijuana Business Conference and Expo. Shimadzu’s high-performance ... solvents, heavy metals, and more. Expo attendees can stop by booth 1021 to ...
(Date:4/27/2016)... ... April 27, 2016 , ... The Board ... the appointment of John Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven ... the founding commercial leaders responsible for the commercialization of multiple orphan drug indications. ...
(Date:4/27/2016)... ... April 27, 2016 , ... Global Stem Cells Group ... an Asia-Pacific Symposium as other research and development initiatives for potential stem cell protocol ... top Global Stem Cells Group executives began meeting to establish a working agenda and ...
Breaking Biology Technology:
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/15/2016)... , April 15, 2016  A new ... make more accurate underwriting decisions in a fraction ... timely, competitively priced and high-value life insurance policies ... screenings. With Force Diagnostics, rapid testing ... lifestyle data readings (blood pressure, weight, pulse, BMI, ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
Breaking Biology News(10 mins):